Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Tyler Technologies
TYL
$14.3B
| $17M | 0.01% |
37,019
+33,952
| +1,107% | +$16.2M |
|
1452
System1
SST
$16.5M
| $17M | 0.01% |
171,250
+26,409
| +18% | +$2.61M |
|
1453
Louisiana-Pacific
LPX
$5.06B
| $16.9M | 0.01% |
276,093
-843,053
| -75% | -$49.7M |
|
1454
Assured Guaranty
AGO
$3.3B
| $16.9M | 0.01% |
361,920
-32,555
| -8% | -$1.56M |
|
|
1455
PUT
Linde
LIN
$225B
| $16.9M | 0.01% |
57,700
+28,000
| +94% | +$8.51M |
|
|
LICY
1456
DELISTED
Li-Cycle Holdings Corp.
LICY
| $16.9M | 0.01% |
+187,590
| New | +$13.8M |
|
|
HHR
1457
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
| $16.9M | 0.01% |
346,369
+52,584
| +18% | +$2.54M |
|
|
FTPA
1458
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $16.9M | 0.01% |
1,731,453
-37,463
| -2% | -$365K |
|
1459
Lear
LEA
$8.23B
| $16.9M | 0.01% |
107,769
+29,605
| +38% | +$4.85M |
|
1460
CALL
Datadog
DDOG
$80.1B
| $16.9M | 0.01% |
119,300
+81,100
| +212% | +$10.2M |
|
|
FIRY
1461
Firy Inc
FIRY
$154M
| $16.8M | 0.01% |
85,746
+78,438
| +1,073% | +$20.3M |
|
|
AMPS
1462
DELISTED
Altus Power
AMPS
| $16.8M | 0.01% |
1,695,911
+403,968
| +31% | +$4M |
|
1463
CALL
Vanguard High Dividend Yield ETF
VYM
$83.1B
| $16.8M | 0.01% |
+162,700
| New | +$17.2M |
|
1464
Equitable Holdings
EQH
$13.3B
| $16.8M | 0.01% |
565,796
-603,555
| -52% | -$18.3M |
|
1465
CALL
Toronto Dominion Bank
TD
$197B
| $16.8M | 0.01% |
+200,000
| New | +$13.3M |
|
1466
PUT
Roku
ROKU
$23.7B
| $16.8M | 0.01% |
53,500
-35,000
| -40% | -$13.2M |
|
1467
Global Net Lease
GNL
$2.14B
| $16.8M | 0.01% |
1,045,722
+1,035,419
| +10,050% | +$18.2M |
|
1468
Atkore
ATKR
$3.16B
| $16.7M | 0.01% |
192,627
+100,771
| +110% | +$8.39M |
|
1469
Cadence Design Systems
CDNS
$91.4B
| $16.7M | 0.01% |
110,435
+42,462
| +62% | +$6.47M |
|
|
IMGN
1470
DELISTED
Immunogen Inc
IMGN
| $16.7M | 0.01% |
2,947,521
+324,613
| +12% | +$1.88M |
|
1471
PUT
Iron Mountain
IRM
$36B
| $16.7M | 0.01% |
384,200
-291,300
| -43% | -$13.1M |
|
1472
Synchrony
SYF
$26.3B
| $16.7M | 0.01% |
341,156
-201,996
| -37% | -$9.82M |
|
1473
PUT
Vertex Pharmaceuticals
VRTX
$140B
| $16.7M | 0.01% |
91,900
-16,400
| -15% | -$3.2M |
|
1474
The Greenbrier Companies
GBX
$1.43B
| $16.6M | 0.01% |
386,432
+177,259
| +85% | +$7.64M |
|
1475
Gerdau
GGB
$8.55B
| $16.6M | 0.01% |
4,252,377
-2,342,326
| -36% | -$10.2M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.